poloxalene has been researched along with Cancer of Lung in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Q; Li, J; Qin, L; Shi, W; Wang, H; Wen, H; Xie, J; Yu, X; Zeng, D; Zhou, Y | 1 |
| Cierniak, A; Komarnicka, UK; Kołoczek, P; Kyzioł, A; Płotek, M; Sebastian, V; Skórska-Stania, A | 1 |
| Chen, Q; Chen, Y; Han, X; He, W; Lu, E; Sha, X; Sun, Y | 1 |
| Budillon, A; Caetano, W; Hioka, N; Milone, MR; Pagliara, V; Pellosi, DS; Pucci, B; Quaglia, F; Russo, A; Russo, G; Ungaro, F | 1 |
| Chen, Y; Fang, X; Hao, J; Luo, J; Sha, X; Shi, Y; Yu, S; Zhang, W | 1 |
| Chen, L; Li, Y; Shen, J; Yin, Q; Zhang, Z | 1 |
| Chen, YL; Dai, GC; Tan, WS | 1 |
7 other study(ies) available for poloxalene and Cancer of Lung
| Article | Year |
|---|---|
pH-activated, mitochondria-targeted, and redox-responsive delivery of paclitaxel nanomicelles to overcome drug resistance and suppress metastasis in lung cancer.
Topics: A549 Cells; Antineoplastic Agents; Apoptosis; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Hydrogen-Ion Concentration; Lung Neoplasms; Micelles; Mitochondria; Mitochondrial Membranes; Nanoparticles; Oxidation-Reduction; Paclitaxel; Poloxalene | 2021 |
Polymeric micelle-mediated delivery of half-sandwich ruthenium(II) complexes with phosphanes derived from fluoroloquinolones for lung adenocarcinoma treatment.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cisplatin; Coordination Complexes; DNA Fragmentation; Drug Carriers; Fluoroquinolones; Humans; Inhibitory Concentration 50; Lung Neoplasms; Micelles; Nanoparticles; Phosphines; Poloxalene; Ruthenium | 2018 |
Leukocyte-mimicking Pluronic-lipid nanovesicle hybrids inhibit the growth and metastasis of breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Carriers; Female; Humans; Leukocytes; Lipid Bilayers; Lung Neoplasms; Matrix Metalloproteinase 9; Membrane Proteins; Mice; Mice, Inbred BALB C; Nanostructures; Neutrophils; Paclitaxel; Poloxalene | 2019 |
Biotin-targeted Pluronic(®) P123/F127 mixed micelles delivering niclosamide: A repositioning strategy to treat drug-resistant lung cancer cells.
Topics: A549 Cells; Animals; Antineoplastic Agents; Biotin; Cell Survival; Dose-Response Relationship, Drug; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Mice; Micelles; Niclosamide; NIH 3T3 Cells; Poloxalene; Poloxamer; Ribosomal Protein L3 | 2016 |
Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Non-Small-Cell Lung; Drug Delivery Systems; Drug Resistance, Neoplasm; Humans; Lung Neoplasms; Micelles; Paclitaxel; Poloxalene | 2010 |
Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Imines; Inhibitor of Apoptosis Proteins; Lung Neoplasms; Male; Mice; Mice, Nude; Paclitaxel; Poloxalene; Polyethylene Glycols; Polyethylenes; RNA, Small Interfering; Survivin; Vitamin E | 2012 |
Quantitative investigations of cell-bubble interactions using a foam fractionation technique.
Topics: Adsorption; Animals; Antibodies, Monoclonal; Antifoaming Agents; Biotechnology; Blood; Carcinoma, Small Cell; Cattle; Cell Survival; Culture Media, Serum-Free; Culture Techniques; Humans; Hybridomas; Immunoglobulin G; Kinetics; Lung Neoplasms; Mice; Models, Theoretical; Poloxalene | 1994 |